Abstract Tumour progression fundamentally disrupts extracellular matrix (ECM) homeostasis, generating circulating molecular signatures that reflect the integrated activities of cancer cells, stromal fibroblasts and infiltrating immune populations. These tumour ECM-derived fragments comprise specific protease-generated neo-epitopes of collagens, proteoglycans and glycoproteins, and provide dynamic, real-time readouts of microenvironmental remodelling that distinguish them from other classes of […]
Beyond the tumour: circulating extracellular matrix fragments as next-generation cancer biomarkers.
November 12, 2026
Nat Rev Cancer